Viability study of a multiplex diagnostic platform for Chagas disease

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue SUPPL. 1, 2009, Pages 136-141

  Foti, Leonardo ^a   Fonseca, Bruna de Paula Fonseca ^b   Nascimento, Lilian Dias ^b   Marques, Christiane de Fatima Silva ^b   da Silva, Edmilson Domingos ^b   Duarte, Cesar Augusto Barros ^a   Probst, Christian M ^a   Goldenberg, Samuel ^a   Pinto, Antônio Gomes ^b   Krieger, Marco Aurélio ^a  

^a INSTITUTO CARLOS CHAGAS   (Brazil)

^b Instituto de Technologia em Imunobiologicos   (Brazil)

Author keywords

Bead based assay; Chagas disease; Diagnostic; Multiplex; Trypanosoma cruzi

Indexed keywords

TRYPANOSOMA CRUZI;

EID: 68949209380     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000900019     Document Type: Article

References (30)

1. Brener Z, Andrade ZA, Barral-Neto M 2000. Trypanossoma cruzi e doença de Chagas. Guanabara Koogan, Rio de Janeiro, 431 pp.
2. Burgess DCH, Wasserman J, Dahl CA 2006. Global health diagnostics. Nature 444 (Suppl. 1): 1-2.
3. Chagas C 1909. Nova tripanozomiase humana. Estudos sobre a morfolojía e o ciclo evolutivo de Schizotrypanum cruzi n.gen., n.sp., ajente etiolójico de nova entidade morbida do homen. Mem Inst Oswaldo Cruz 1: 159-218.
4. Chen Y, Qiu S, Luan CH, Luo M 2008. A high throughput platform for eukaryotic genes. Methods Mol Biol 426: 209-220.
5. Cooley G, Etheridge RD, Boehlke C, Bundy B, Weatherly DB, Minning T, Haney M, Postan M, Laucella S, Tarleton RL 2008. High throughput selection of effective serodiagnostics for Trypanosoma cruzi infection. PLoS Med 2: e316.
6. Coura JR 2007. Chagas disease: what is known and what is needed - a background article. Mem Inst Oswaldo Cruz 102 (Suppl. I): 113-122.
7. Dias D, Van Doren J, Schlottmann S, Kelly S, Puchalski D, Ruiz W, Boerckel P, Kessler J, Antonello JM, Green T, Brown M, Smith J, Chirmule N, Barr E, Jansen KU, Esser MT 2005. Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16 and 18. Clin Diagn Lab Immunol 12: 959-969.
8. El-Sayed NM, Myler PJ, Bartholomeu DC, Nilsson D, Aggarwal G, Tran AN, Ghedin E, Worthey EA, Delcher AL, Blandin G, Westenberger SJ, Caler E, Cerqueira GC, Branche C, Haas B, Anupama A, Arner E, Aslund L, Attipoe P, Bontempi E, Bringaud F, Burton P, Cadag E, Campbell DA, Carrington M, Crabtree J, Darban H, da Silveira JF, de Jong P, Edwards K, Englund PT, Fazelina G, Feldblyum T, Ferella M, Frasch AC, Gull K, Horn D, Hou L, Huang Y, Kindlund E, Klingbeil M, Kluge S, Koo H, Lacerda D, Levin MJ, Lorenzi H, Louie T, Machado CR, McCulloch R,McKenna A, Mizuno Y, Mottram JC, Nelson S, Ochaya S, Osoegawa K, Pai G, Parsons M, Pentony M, Pettersson U, Pop M, Ramirez JL, Rinta J, Robertson L, Salzberg SL, Sanchez DO, Seyler A, Sharma R, Shetty J, Simpson AJ, Sisk E, Tammi MT, Tarleton R, Teixeira S, Van Aken S, Vogt C, Ward PN, Wickstead B, Wortman J, White O, Fraser CM, Stuart KD, Andersson B 2005. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 309: 409-415.
9. Hopkins AL, Witty MJ, Nwaka S 2007. Mission possible. Nature 449: 166-169.
10. Jani IV, Janossy G, Brown DW, Mandy F 2002. Multiplexed immunoassays by flow cytometry for diagnosis and surveillance of infectious diseases in resource-poor settings. Lancet Infect Dis 2: 243-250.
11. Joos TO, Stoll D, Templin MF 2002. Miniaturised multiplexed immunoassays. Curr Opin Chem Biol 6: 76-80.
12. King DA, Peckham C, Waage JK, Brownlie J, Woolhouse ME 2006. Epidemiology. Infectious diseases: preparing for the future. Science 313: 1392-1393.
13. Krieger MA, Almeida E, Oelemann W, Lafaille JJ, Pereira JB, Krieger H, Carvalho MR, Goldenberg S 1992. Use of recombinant antigens for the accurate immunodiagnosis of Chagas' disease. Am J Trop Med Hyg 46: 427-434.
14. Lal G, Balmer P, Joseph H, Dawson M, Borrow R 2004. Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y and W-135. Clin Diagn Lab Immunol 11: 272-279.
15. Lee SH, Walker DR, Cregan PB, Boerma HR 2004. Comparison of four flow cytometric SNP detection assays and their use in plant improvement. Theor Appl Genet 110: 167-174.
16. Leon JS, Godsel LM, Wang K, Engman DM 2001. Cardiac myosin autoimmunity in acute Chagas' heart disease. Infect Immun 69: 5643-5649.
17. López-Antuñano FJ 1997. Quimioterapia de las infecciones producidas por Trypanosoma cruzi. Salud Publica Mex 39: 463-471.
18. Luan CH, Qiu S, Finley JB, Carson M, Gray RJ, Huang W, Johnson D, Tsao J, Reboul J, Vaglio P, Hill DE, Vidal M, Delucas LJ, Luo M 2004. High-throughput expression of C. elegans proteins. Genome Res 14: 2102-2110.
19. Martins TB, Burlingame R, von Mühlen CA, Jaskowski TD, Litwin CM, Hill HR 2004. Evaluation of multiplexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens. Clin Diagn Lab Immunol 11: 1054-1059.
20. MSF - Médecins Sans Frontières 2008. Campaign for access to essential medicines. International meeting. New diagnostic tests are urgently needed to treat patients with Chagas disease. Rev Soc Bras Med Trop 41: 315-319.
21. O'Connell D 2007. Neglected diseases. Nature 449: 157-182.
22. O'Meara WP, Hall BF, McKenzie FE 2007. Malaria vaccine efficacy: the difficulty of detecting and diagnosing malaria. Malar J 6: 36.
23. Prabhakar U, Eirikis E, Davis HM 2002. Simultaneous quantification of proinflammatory cytokines in human plasma using the LabMAP assay. J Immunol Methods 260: 207-218.
24. Rual JF, Hill DE, Vidal M 2004. ORFeome projects: gateway between genomics and omics. Curr Opin Chem Biol 8: 20-25.
25. Schmunis GA, Cruz JR 2005. Safety of the blood supply in Latin America. Clin Microbiol Rev 18: 12-29.
26. TDR 2007. Reporte del grupo de trabajo científico sobre la enfermedad de Chagas, 2005. Availble from: http://apps.who.int/tdr/publications/tdr-research-publications/reporte-enfermedad-chagas/pdf/swg_chagas.pdf. [Accessed January, 5th, 2009].
27. Urdea M, Penny LA, Olmsted SS, Giovanni MY, Kaspar P, Shepherd A, Wilson P, Dahl CA, Buchsbaum S, Moeller G, Hay Burgess DC 2006. Requirements for high impact diagnostics in the developing world. Nature 444 (Suppl. 1): 73-79.
28. Vignali DAA 2000. Multiplexed particle-based flow cytometric assays. J Immunol Methods 243: 243-255.
29. Villa L, Morote S, Bernal O, Bulla D, Albajar-Vinas P 2007. Access to diagnosis and treatment of Chagas disease/infection in endemic and non-endemic countries in the XXI century. Mem Inst Oswaldo Cruz 102 (Suppl. I): 87-94.
30. Yan X, Zhong W, Tang A, Schielke EG, Hang W, Nolan JP 2005. Multiplexed flow cytometric immunoassay for influenza virus detection and differentiation. Anal Chem 77: 7673-7678.